Sznol, M.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Traces of the Targum Sources in Greek Bible Translations in the Hebrew Alphabet

Journal:

Journal for the Study of the Pseudepigrapha

Year:

2014

Language:

english

File:

PDF, 280 KB

english, 2014

2

Introducing a New Series: Immunotherapy Facts and Hopes

Melero, Ignacio, Sznol, Mario, Tessmer, Marlowe S., Whiteside, Theresa L., Wolchok, Jedd D.

Journal:

Clinical Cancer Research

Year:

2018

Language:

english

File:

PDF, 163 KB

english, 2018

3

Characterizing the Business Skills of the Public Health Workforce

Kornfeld, Julie, Sznol, Joshua, Lee, David

Journal:

Journal of Public Health Management and Practice

Year:

2015

Language:

english

File:

PDF, 121 KB

english, 2015

4

Combination Therapy with Anti-CTLA-4 and Anti-PD-1 Leads to Distinct Immunologic Changes In Vivo

Das, R., Verma, R., Sznol, M., Boddupalli, C. S., Gettinger, S. N., Kluger, H., Callahan, M., Wolchok, J. D., Halaban, R., Dhodapkar, M. V., Dhodapkar, K. M.

Journal:

The Journal of Immunology

Year:

2015

Language:

english

File:

PDF, 1.09 MB

english, 2015

5

Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies

Paolo A. Ascierto, Ester Simeone, Mario Sznol, Yang-Xin Fu, Ignacio Melero

Journal:

Seminars in Oncology

Year:

2010

Language:

english

File:

PDF, 254 KB

english, 2010

6

Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer

Sznol, M., Chen, L.

Journal:

Clinical Cancer Research

Year:

2013

Language:

english

File:

PDF, 661 KB

english, 2013

7

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

Fyfe, G, Fisher, R I, Rosenberg, S A, Sznol, M, Parkinson, D R, Louie, A C

Journal:

Journal of Clinical Oncology

Year:

1995

Language:

english

File:

PDF, 702 KB

english, 1995

8

9306 Phase II multi-institution trial of ipilimumab for patients with melanoma and brain metastasis

Margolin, K., Lawrence, D., Hamid, O., McDermott, D., Puzanov, I., Sznol, M., Richards, J., Clark, J., Logan, T., Hodi, S.

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 49 KB

english, 2009

9

Use of Prophylactic Antibiotics for Prevention of Intravascular Catheter-Related Infections in Interleukin-2-Treated Patients

HARTMANN, L. C., URBA, W. J., STEIS, R. G., SMITH, J. W., VANDERMOLEN, L. A., CREEKMORE, S. P., SZNOL, M., CASCIANO, M. A., ENGLER, N., LONGO, D. L.

Journal:

JNCI Journal of the National Cancer Institute

Year:

1989

Language:

english

File:

PDF, 429 KB

english, 1989

10

1137PDIdentification of adenosine pathway genes associated with response to therapy with the adenosine receptor antagonist CPI-444

Willingham, S, Hotson, A N, Laport, G, Kwei, L, Fong, L, Sznol, M, Powderly, J, Miller, R

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 94 KB

english, 2018

11

Therapeutic Combinations of Immune-Modulating Antibodies in Melanoma and Beyond

Cohen, Justine, Sznol, Mario

Journal:

Seminars in Oncology

Year:

2015

Language:

english

File:

PDF, 444 KB

english, 2015

12

Phase I Study of High-Dose Continuous-Infusion Recombinant Interleukin-2 and Autologous Lymphokine-Activated Killer Cells in Patients With Metastatic or Unresectable Malignant Melanoma and Renal Cell Carcinoma

Gaynor, E. R., Weiss, G. R., Margolin, K. A., Aronson, F. R., Sznol, M., Demchak, P., Grima, K. M., Fisher, R. I., Boldt, D. H., Doroshow, J. H., Bar, M. H., Hawkins, M. J., Mier, J. W., Caliendo, G.

Journal:

JNCI Journal of the National Cancer Institute

Year:

1990

Language:

english

File:

PDF, 557 KB

english, 1990

13

Immunotherapy of melanoma: facts and hopes

Weiss, Sarah A, Wolchok, Jedd D., Sznol, Mario

Journal:

Clinical Cancer Research

Year:

2019

Language:

english

File:

PDF, 1.06 MB

english, 2019

14

Programmed death ligand-1 expression in non-small cell lung cancer

Velcheti, Vamsidhar, Schalper, Kurt A, Carvajal, Daniel E, Anagnostou, Valsamo K, Syrigos, Konstantinos N, Sznol, Mario, Herbst, Roy S, Gettinger, Scott N, Chen, Lieping, Rimm, David L

Journal:

Laboratory Investigation

Year:

2014

Language:

english

File:

PDF, 498 KB

english, 2014

15

Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma

Ott, P. A., Hamid, O., Pavlick, A. C., Kluger, H., Kim, K. B., Boasberg, P. D., Simantov, R., Crowley, E., Green, J. A., Hawthorne, T., Davis, T. A., Sznol, M., Hwu, P.

Journal:

Journal of Clinical Oncology

Year:

2014

Language:

english

File:

PDF, 254 KB

english, 2014

16

Phase I and Pharmacokinetic Study of the Ribonucleotide Reductase Inhibitor, 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, Administered by 96-Hour Intravenous Continuous Infusion

Wadler, S., Makower, D., Clairmont, C., Lambert, P., Fehn, K., Sznol, M.

Journal:

Journal of Clinical Oncology

Year:

2004

Language:

english

File:

PDF, 235 KB

english, 2004

17

Phase I Trial of Triapine–Cisplatin–Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers

Kunos, Charles A., Chu, Edward, Makower, Della, Kaubisch, Andreas, Sznol, Mario, Ivy, Susan Percy

Journal:

Frontiers in Oncology

Year:

2017

Language:

english

File:

PDF, 515 KB

english, 2017

18

Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen.

Parkinson, D R, Fisher, R I, Rayner, A A, Paietta, E, Margolin, K A, Weiss, G R, Mier, J W, Sznol, M, Gaynor, E R, Bar, M H

Journal:

Journal of Clinical Oncology

Year:

1990

Language:

english

File:

PDF, 581 KB

english, 1990

19

Tumour therapy using Salmonella

King, I, Luo, X, Feng, M, Ittensohn, M, Li, Z, Belcourt, M, Lin, S, Le, T, Pike, J, Troy, K, Sznol, M, Clairmont, C, Bermudes, D, Zheng, L-M

Journal:

Expert Opinion on Emerging Drugs

Year:

2000

Language:

english

File:

PDF, 145 KB

english, 2000

20

Expanded Use Trials—Are There Better Approaches to Minimize Adverse Consequences to the Clinical Trials Program?

Journal:

The Cancer Journal

Year:

2014

Language:

english

File:

PDF, 140 KB

english, 2014

21

A Serum Protein Signature Associated with Outcome After Anti-PD1 Therapy in Metastatic Melanoma

Weber, Jeffrey S., Sznol, Mario, Sullivan, Ryan J., Blackmon, Shauna, Boland, Genevieve, Kluger, Harriet M, Halaban, Ruth, Bacchiocchi, Antonella, Ascierto, Paolo A, Capone, Marilena, Oliveira, Carlos

Journal:

Cancer Immunology Research

Year:

2017

Language:

english

File:

PDF, 952 KB

english, 2017

22

Outcomes of Melanoma Brain Metastasis Management with Gamma Knife Radiosurgery +/- Ipilimumab

J. Knisely, V.L.S. Chiang, H.M. Kluger, J.C. Flanigan, M. Sznol, J.B. Yu

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

23

Melanoma: A model for testing new agents in combination therapies

Paolo A Ascierto, Howard Z Streicher, Mario Sznol

Journal:

Journal of Translational Medicine

Year:

2010

Language:

english

File:

PDF, 668 KB

english, 2010

24

Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab

McDermott, D. F., Drake, C. G., Sznol, M., Choueiri, T. K., Powderly, J. D., Smith, D. C., Brahmer, J. R., Carvajal, R. D., Hammers, H. J., Puzanov, I., Hodi, F. S., Kluger, H. M., Topalian, S. L., Pa

Journal:

Journal of Clinical Oncology

Year:

2015

Language:

english

File:

PDF, 821 KB

english, 2015

25

Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors

Stamatouli, Angeliki M., Quandt, Zoe, Perdigoto, Ana Luisa, Clark, Pamela L., Kluger, Harriet, Weiss, Sarah A., Gettinger, Scott, Sznol, Mario, Young, Arabella, Rushakoff, Robert, Lee, James, Blueston

Journal:

Year:

2018

Language:

english

File:

PDF, 881 KB

english, 2018

26

Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205

Dhodapkar, M. V., Sznol, M., Zhao, B., Wang, D., Carvajal, R. D., Keohan, M. L., Chuang, E., Sanborn, R. E., Lutzky, J., Powderly, J., Kluger, H., Tejwani, S., Green, J., Ramakrishna, V., Crocker, A.,

Journal:

Science Translational Medicine

Year:

2014

Language:

english

File:

PDF, 1.43 MB

english, 2014

27

Melanoma patients with durable responses to IL-2 treatment

Lotze, M, Atkins, M, Dutcher, J, Fisher, R, Margolin, K, Weiss, G, Abrams, J, Sznol, M, Parkinson, D, Hawkins, M, Paradise, C, Rosenberg, S A

Journal:

Melanoma Research

Year:

1997

File:

PDF, 107 KB

1997

28

Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical Implications

Halaban, Ruth, Krauthammer, Michael, Pelizzola, Mattia, Cheng, Elaine, Kovacs, Daniela, Sznol, Mario, Ariyan, Stephan, Narayan, Deepak, Bacchiocchi, Antonella, Molinaro, Annette, Kluger, Yuval, Deng,

Journal:

Year:

2009

Language:

english

File:

PDF, 1.85 MB

english, 2009

29

A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer

Yun Yen, Kim Margolin, James Doroshow, Mayer Fishman, Bonny Johnson, Caroline Clairmont, Dan Sullivan, Mario Sznol

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2004

Language:

english

File:

PDF, 233 KB

english, 2004

30

Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival

Knisely, Jonathan P. S., Yu, James B., Flanigan, Jaclyn, Sznol, Mario, Kluger, Harriet M., Chiang, Veronica L. S.

Journal:

Journal of Neurosurgery

Year:

2012

Language:

english

File:

PDF, 1.31 MB

english, 2012

31

Acute leukemia in adult Hispanic Americans: a large-population study

Swords, R, Sznol, J, Elias, R, Watts, J, Zelent, A, Martin, E, Vargas, F, Bethel-Ellison, S, Kobetz, E

Journal:

Blood Cancer Journal

Year:

2016

Language:

english

File:

PDF, 101 KB

english, 2016

32

Evaluation of classical clinical endpoints as surrogates for overall survival in patients treated with immune checkpoint blockers: a systematic review and meta-analysis

Kaufman, Howard L., Schwartz, Lawrence H., William, William N., Sznol, Mario, Fahrbach, Kyle, Xu, Yingxin, Masson, Eric, Vergara-Silva, Andrea

Journal:

Journal of Cancer Research and Clinical Oncology

Year:

2018

File:

PDF, 1.33 MB

2018

33

Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study.

Parkinson, D R, Abrams, J S, Wiernik, P H, Rayner, A A, Margolin, K A, Van Echo, D A, Sznol, M, Dutcher, J P, Aronson, F R, Doroshow, J H

Journal:

Journal of Clinical Oncology

Year:

1990

Language:

english

File:

PDF, 601 KB

english, 1990

34

Adenosine A2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

Fong, Lawrence, Hotson, Andrew, Powderly, John, Sznol, Mario, Heist, Rebecca S., Choueiri, Toni K., George, Saby, Hughes, Brett GM, Hellmann, Matthew D., Shepard, Dale R, Rini, Brian I., Kummar, Shiva

Journal:

Cancer Discovery

Year:

2019

File:

PDF, 3.69 MB

2019

35

RBTT-07. A PHASE 2 TRIAL OF PEMBROLIZUMAB AND BEVACIZUMAB IN MELANOMA BRAIN MET PATIENTS

Kluger, Harriet M, Forsyth, Peter, Khushalani, Nikhil, Eroglu, Zeynep, Sznol, Mario, Tran, Thuy, Jilaveanu, Lucia, Cohen, Justine V, Hegde, Upendra, Wei, Wei, Mahajan, Amit, Goldberg, Sarah B, Chiang,

Journal:

Year:

2019

File:

PDF, 89 KB

2019

36

Vascularity of primary and metastatic renal cell carcinoma specimens

Saadia A Aziz, Joshua Sznol, Adebowale Adeniran…

Journal:

Journal of Translational Medicine

Year:

2013

Language:

english

File:

PDF, 530 KB

english, 2013

37

Ipilimumab-induced Perforating Colitis

Mitchell, Kisha A., Kluger, Harriet, Sznol, Mario, Hartman, Douglas J.

Journal:

Journal of Clinical Gastroenterology

Year:

2013

Language:

english

File:

PDF, 584 KB

english, 2013

38

PD-L1 Studies Across Tumor Types, its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors

Kluger, Harriet M, Zito, Christopher R., Turcu, Gabriela, Baine, Marina, Zhang, Hongyi, Adeniran, Adebowale, Sznol, Mario, Rimm, David L., Kluger, Yuval, Chen, Lieping, Cohen, Justine V, Jilaveanu, Lu

Journal:

Clinical Cancer Research

Year:

2017

Language:

english

File:

PDF, 12.13 MB

english, 2017

39

Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management

Sznol, Mario, Postow, Michael A., Davies, Marianne J., Pavlick, Anna C., Plimack, Elizabeth R., Shaheen, Montaser, Veloski, Colleen, Robert, Caroline

Journal:

Cancer Treatment Reviews

Year:

2017

Language:

english

File:

PDF, 636 KB

english, 2017

40

Release the Hounds! Activating the T-Cell Response to Cancer

Sznol, Mario, Longo, Dan L.

Journal:

New England Journal of Medicine

Year:

2015

Language:

english

File:

PDF, 365 KB

english, 2015

41

Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma

Wallin, Jeffrey J., Bendell, Johanna C., Funke, Roel, Sznol, Mario, Korski, Konstanty, Jones, Suzanne, Hernandez, Genevive, Mier, James, He, Xian, Hodi, F. Stephen, Denker, Mitchell, Leveque, Vincent,

Journal:

Nature Communications

Year:

2016

Language:

english

File:

PDF, 1006 KB

english, 2016

42

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

McDermott, David F., Huseni, Mahrukh A., Atkins, Michael B., Motzer, Robert J., Rini, Brian I., Escudier, Bernard, Fong, Lawrence, Joseph, Richard W., Pal, Sumanta K., Reeves, James A., Sznol, Mario,

Journal:

Nature Medicine

Year:

2018

Language:

english

File:

PDF, 1.72 MB

english, 2018

43

Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer.

Curti, B D, Ochoa, A C, Powers, G C, Kopp, W C, Alvord, W G, Janik, J E, Gause, B L, Dunn, B, Kopreski, M S, Fenton, R, Zea, A, Dansky-Ullmann, C, Strobl, S, Harvey, L, Nelson, E, Sznol, M, Longo, D L

Journal:

Journal of Clinical Oncology

Year:

1998

File:

PDF, 801 KB

1998

44

1251PPathologic scoring of pre-treatment H&E biopsies predicts overall survival in patients with metastatic clear cell renal cell carcinoma receiving nivolumab monotherapy

Stein, J E, Signoretti, S, Sznol, M, Ishii, Y, McDermott, D F, Choueiri, T K, Taube, J M

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 76 KB

2019

45

The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization

Harriet M Kluger, Mary M McCarthy, Ayesha B Alvero, Mario Sznol, Stephan Ariyan, Robert L Camp, David L Rimm, Gil Mor

Journal:

Journal of Translational Medicine

Year:

2007

Language:

english

File:

PDF, 4.49 MB

english, 2007

46

Pilot Study of Interleukin-2 and Lymphokine-Activated Killer Cells Combined With Immunomodulatory Doses of Chemotherapy and Sequenced With Interferon Alfa-2a in Patients With Metastatic Melanoma and Renal Cell Carcinoma

Sznol, M., Clark, J. W., Smith, J. W., Steis, R. G., Urba, W. J., Rubinstein, L. V., VanderMolen, L. A., Janik, J., Sharfman, W. H., Fenton, R. G., Creekmore, S. P., Kremers, P., Conlon, K., Hersey, J

Journal:

JNCI Journal of the National Cancer Institute

Year:

1992

Language:

english

File:

PDF, 881 KB

english, 1992

47

Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab

Sznol, Mario, Fishman, Mayer, Escudier, Bernard, McDermott, David F, Kluger, Harriet, Stadler, Walter M, Perez-Gracia, Jose, McNeel, Douglas G, Curti, Brendan D, Harrison, Michael R, Plimack, Elizabet

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2015

Language:

english

File:

PDF, 262 KB

english, 2015

48

A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders

Judith E. Karp, Francis J. Giles, Ivana Gojo, Lawrence Morris, Jacqueline Greer, Bonny Johnson, Mya Thein, Mario Sznol, Jennifer Low

Journal:

Leukemia Research

Year:

2008

Language:

english

File:

PDF, 117 KB

english, 2008

49

Betting on immunotherapy for melanoma

Journal:

Current Oncology Reports

Year:

2009

Language:

english

File:

PDF, 298 KB

english, 2009

50

Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032

Jill C Rubinstein, Mario Sznol, Anna C Pavlick, Stephan Ariyan, Elaine Cheng, Antonella Bacchiocchi, Harriet M Kluger, Deepak Narayan, Ruth Halaban

Journal:

Journal of Translational Medicine

Year:

2010

Language:

english

File:

PDF, 918 KB

english, 2010

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски